Diamondback Energy enters the week of July 7 with shorts unwinding steadily, the borrow market sitting at its loosest in months, and a Street consensus that still prices in roughly 30% upside — yet the stock closed Tuesday at $180.56, still nursing a 6% monthly loss.
The short-side story is one of persistent retreat. Short interest has fallen 15% over the past month to just 3% of the free float, down from above 5% in early June when a one-day spike pushed shares short briefly above 14 million. That early-June burst — likely tied to the $2 billion block sale by SGF FANG Holdings on June 4 — has fully unwound. Borrow conditions confirm the exit: availability has expanded to roughly 2,394% of outstanding short interest, meaning lenders are sitting on more than 128 million shares available against fewer than 9 million actually borrowed. Borrowing costs have drifted back to 0.42%, near their softest level in 30 days. The ORTEX short score, at 37.9, has edged lower all week — positioning looks genuinely undemanding rather than crowded.
Options traders are equally relaxed. The put/call ratio has dropped to 0.54, sitting just below its 20-day average of 0.57 and near the lower end of its recent range. The z-score of -0.77 confirms the tilt toward calls rather than puts — a mild bullish lean compared to where the ratio stood in mid-June, when hedging demand pushed it above 0.63 for two weeks running. The combined picture in derivatives and short lending is one of low friction: neither bears nor hedgers are pressing hard ahead of the August 3 earnings date.
The Street is broadly onside, though target prices have quietly drifted lower. Morgan Stanley trimmed its target to $216 from $229 last week, keeping an Overweight rating. That trim matters because it moves against the direction of travel seen through May, when Citi, Barclays, Mizuho, Bernstein, and Susquehanna all raised targets into the $225–$262 range after Q1 results. The consensus target of $232 still implies roughly 28% upside from current levels — a gap that reflects the stock's 13% drift lower since mid-May rather than any fundamental downgrade. Valuation backs the bull case modestly: the stock trades at 9.6x trailing earnings and 5.6x EV/EBITDA, multiples that have compressed about 11 points and 0.14x respectively over the past 30 days. Forward EPS momentum ranks in the 96th percentile across the ORTEX universe — the estimate revision story remains among the strongest in the market — but the near-term EPS surprise rank sits at just 20, a reminder that Q1 landed with a one-day loss of nearly 9%.
That reaction history is worth noting ahead of August 3. The last three earnings prints each produced negative five-day returns, averaging around -6%. The single-day move after the May print was -8.7% — the sharpest post-earnings decline in the dataset. On the institutional side, the dominant ownership event of the past month was the 10-million-share sale by SGF FANG Holdings, which trimmed its stake from 26.3% to roughly 22.6%; CEO Matthew Kaes Van't Hof sold $3.1 million of stock on June 3 alongside the CLO and Chief Accounting Officer, all at prices between $205 and $210 — well above where the stock trades today. Peers moved broadly in line this week, with PR, MTDR, and APA each gaining 3–5% on Tuesday alongside FANG's 3.9% session.
The setup heading into the August 3 report is therefore less about short pressure — which has effectively collapsed — and more about whether Diamondback can print a quarter that breaks its recent pattern of disappointing the day-one trade, at a price that has given back most of the post-Q1 bounce.
See the live data behind this article on ORTEX.
Open FANG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
